Other
Other Noncash Income (Expense)
West Pharmaceutical Services Other Noncash Income (Expense) decreased by 133.3% to -$1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 134.5%, from $2.90M to -$1.00M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
Metric ID:
other_other_noncash_income_expenseHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.10M | $177.60M | $7.50M | $4.10M | $6.30M | $6.50M | $5.90M | $1.10M | -$14.50M | $3.70M | $3.90M | $2.10M | $2.90M | $4.00M | $3.00M | -$1.00M |
| QoQ Change | — | >999% | -95.8% | -45.3% | +53.7% | +3.2% | -9.2% | -81.4% | <-999% | +125.5% | +5.4% | -46.2% | +38.1% | +37.9% | -25.0% | -133.3% |
| YoY Change | — | — | — | -49.4% | -96.5% | -13.3% | +43.9% | -82.5% | — | -43.1% | -33.9% | +90.9% | -21.6% | +2.6% | — | -134.5% |
Range-$14.50M – $177.60M
CAGR-42.8%
Avg YoY Growth-30.7%
Median YoY Growth-33.9%
Current Streak2 quarters decline
Other Noncash Income (Expense) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other noncash income (expense)?
- West Pharmaceutical Services (WST) reported other noncash income (expense) of -$1.00M in Q1 2026.
- How has West Pharmaceutical Services's other noncash income (expense) changed year-over-year?
- West Pharmaceutical Services's other noncash income (expense) decreased by 134.5% year-over-year, from $2.90M to -$1.00M.